GlucoTrack (GCTK) news

Glucotrack, Inc. announces pricing of $3 million public offering

Glucotrack, Inc. (Nasdaq: GCTK) has announced the pricing of a $3.0 million public offering of approximately 2.6 million shares of common stock at $1.15 per share. The offering, structured as a “best efforts” public offering, is expected to close on or about February 5, 2025, subject to customary…

Glucotrack registers to offer, resell up to 43.45M shrs

Glucotrack Inc. has filed a registration statement with the Securities and Exchange Commission to offer and resell up to 43.45 million shares of its common stock. The company has not specified the intended use of proceeds from the offering, nor has it disclosed the price range or timing for the…

Glucotrack announces $11.5 million financing

Glucotrack, Inc. (NASDAQ: GCTK) has announced a total of $11.5 million in financing over the past year, reflecting continued investor confidence in the company’s development of its continuous blood glucose monitoring (CBGM) technology. The financing includes a $2.0 million equity round priced at…

Glucotrack - Announces 1-for-15 reverse stock split effective August 31, 2026

Glucotrack - enters amendment No. 1 to stock purchase agreement with White Lion Capital on Aug 7th - SEC filing

On August 7, 2026, Glucotrack, Inc. executed Amendment No. 1 to its Stock Purchase Agreement with White Lion Capital, as disclosed in a recent SEC filing. The amendment outlines adjustments to the original terms of the agreement, though specific details of the modifications have not been publicly…